Construction of an RNase P Ribozyme Library System for Functional Genomics ApplicationsAn RNase P ribozyme library has been developed as a tool for functional genomics studies.
('Construction', 'Construction', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('Ribozyme', 'Ribozyme', 'NN', 'I-NP', 'O')
('Library', 'Library', 'JJ', 'I-NP', 'O')
('System', 'System', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('Functional', 'Functional', 'JJ', 'B-NP', 'O')
('Genomics', 'Genomics', 'NNP', 'I-NP', 'O')
('Applications', 'Application', 'NNS', 'I-NP', 'O')
('An', 'An', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('developed', 'develop', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('tool', 'tool', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('studies.', 'studies.', 'NNS', 'I-NP', 'O')
Each clone of this library contains a random 18-mer and the sequence of M1 RNA, the catalytic subunit of RNase P. Repression of target gene expression is thus achieved by the complementary binding of mRNA to the random guide sequence and the successive target cleavage via M1 RNA.
('Each', 'Each', 'DT', 'B-NP', 'O')
('clone', 'clone', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('contains', 'contain', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-protein')
('18-mer', '18-mer', 'NN', 'I-NP', 'I-protein')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sequence', 'sequence', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('M1', 'M1', 'NN', 'B-NP', 'B-protein')
('RNA,', 'RNA,', 'NN', 'I-NP', 'I-protein')
('the', 'the', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein')
('subunit', 'subunit', 'NN', 'I-NP', 'I-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('RNase', 'RNase', 'NN', 'B-NP', 'B-protein')
('P.', 'P.', 'NNP', 'I-NP', 'O')
('Repression', 'Repression', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('target', 'target', 'NN', 'B-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('expression', 'expression', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('thus', 'thus', 'RB', 'I-VP', 'O')
('achieved', 'achieve', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('complementary', 'complementary', 'JJ', 'I-NP', 'O')
('binding', 'binding', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('mRNA', 'mRNA', 'NN', 'B-NP', 'B-RNA')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-DNA')
('guide', 'guide', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('successive', 'successive', 'JJ', 'I-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('cleavage', 'cleavage', 'NN', 'I-NP', 'O')
('via', 'via', 'IN', 'B-PP', 'O')
('M1', 'M1', 'NN', 'B-NP', 'B-protein')
('RNA.', 'RNA.', 'NN', 'I-NP', 'I-protein')
Cellular expression of the ribozyme expression was confirmed, and EGFP mRNA was used as a model to demonstrate that the RNase P ribozyme expression system can inhibit the target gene expression.
('Cellular', 'Cellular', 'JJ', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('confirmed,', 'confirmed,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('EGFP', 'EGFP', 'NN', 'B-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('demonstrate', 'demonstrate', 'VB', 'I-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('inhibit', 'inhibit', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('expression.', 'expression.', 'NN', 'I-NP', 'O')
The constructed RNase P ribozyme library has a complexity of 1.4*10 7 .
('The', 'The', 'DT', 'B-NP', 'O')
('constructed', 'construct', 'VBN', 'I-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('complexity', 'complexity', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('1.4*10', '1.4*10', 'CD', 'B-NP', 'O')
('7', '7', 'CD', 'I-NP', 'O')
('.', '.', '.', 'O', 'O')
This novel library system should become a useful in functional genomics, to identify novel gene functions in mammalian cells.
('This', 'This', 'DT', 'B-NP', 'O')
('novel', 'novel', 'JJ', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('should', 'should', 'MD', 'B-VP', 'O')
('become', 'become', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('useful', 'useful', 'JJ', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('genomics,', 'genomics,', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('novel', 'novel', 'JJ', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('functions', 'function', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('mammalian', 'mammalian', 'JJ', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
Identification of novel gene functions is one of the major goals of biology in the post-genome era.
('Identification', 'Identification', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('novel', 'novel', 'JJ', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('functions', 'function', 'NNS', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('major', 'major', 'JJ', 'I-NP', 'O')
('goals', 'goal', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('biology', 'biology', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('post-genome', 'post-genome', 'JJ', 'I-NP', 'O')
('era.', 'era.', 'NN', 'I-NP', 'O')
A number of approaches have been developed to achieve rapid, high- throughput gene annotation with the phenotype-based functional genomics approach using libraries of genome­ regulating molecules being the most established.
('A', 'A', 'DT', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('approaches', 'approach', 'NNS', 'B-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('developed', 'develop', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('achieve', 'achieve', 'VB', 'I-VP', 'O')
('rapid,', 'rapid,', 'JJ', 'B-NP', 'O')
('high-', 'high-', 'JJ', 'I-NP', 'O')
('throughput', 'throughput', 'NN', 'I-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('annotation', 'annotation', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('phenotype-based', 'phenotype-based', 'JJ', 'I-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('approach', 'approach', 'VBP', 'B-VP', 'O')
('using', 'use', 'VBG', 'I-VP', 'O')
('libraries', 'library', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genome\xad', 'genome\xad', 'NN', 'B-NP', 'B-protein')
('regulating', 'regulate', 'VBG', 'B-VP', 'I-protein')
('molecules', 'molecule', 'NNS', 'B-NP', 'I-protein')
('being', 'be', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('most', 'most', 'RBS', 'I-NP', 'O')
('established.', 'established.', 'JJ', 'I-NP', 'O')
In this strategy, expression of each component of genome­ regulating molecules from the library inhibits target gene expression, and the resulting phenotype is screened in a high- throughput manner.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('strategy,', 'strategy,', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('component', 'component', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genome\xad', 'genome\xad', 'NN', 'B-NP', 'B-protein')
('regulating', 'regulate', 'VBG', 'B-VP', 'I-protein')
('molecules', 'molecule', 'NNS', 'B-NP', 'I-protein')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('inhibits', 'inhibit', 'VBZ', 'B-VP', 'O')
('target', 'target', 'NN', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('expression,', 'expression,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('resulting', 'result', 'VBG', 'I-NP', 'O')
('phenotype', 'phenotype', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('screened', 'screen', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('high-', 'high-', 'JJ', 'I-NP', 'O')
('throughput', 'throughput', 'NN', 'I-NP', 'O')
('manner.', 'manner.', 'NN', 'I-NP', 'O')
This strategy successfully identifiedgenes that are associated with specific phenotypes such as tumorigenesis or metastasis (Begeref a/., 2001; Lee ef a/., 2004; Li et al., 2000; Welch eta!., 2000; Suyama et al., 2003; Suyama et al., 2004).
('This', 'This', 'DT', 'B-NP', 'O')
('strategy', 'strategy', 'NN', 'I-NP', 'O')
('successfully', 'successfully', 'RB', 'B-NP', 'O')
('identified', 'identify', 'VBN', 'I-NP', 'O')
('genes', 'gene', 'NNS', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('specific', 'specific', 'JJ', 'B-NP', 'O')
('phenotypes', 'phenotype', 'NNS', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('tumorigenesis', 'tumorigenesis', 'NN', 'B-NP', 'O')
('or', 'or', 'CC', 'I-NP', 'O')
('metastasis', 'metastasis', 'NN', 'I-NP', 'O')
('(Begeref', '(Begeref', 'NN', 'I-NP', 'O')
('a/.,', 'a/.,', 'NN', 'I-NP', 'O')
('2001;', '2001;', ':', 'O', 'O')
('Lee', 'Lee', 'NNP', 'B-NP', 'O')
('ef', 'ef', 'NN', 'I-NP', 'O')
('a/.,', 'a/.,', 'NN', 'I-NP', 'O')
('2004;', '2004;', ':', 'O', 'O')
('Li', 'Li', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2000;', '2000;', ':', 'O', 'O')
('Welch', 'Welch', 'NNP', 'B-NP', 'O')
('eta!.,', 'eta!.,', 'NNP', 'I-NP', 'O')
('2000;', '2000;', ':', 'O', 'O')
('Suyama', 'Suyama', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2003;', '2003;', ':', 'O', 'O')
('Suyama', 'Suyama', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2004).', '2004).', 'CD', 'B-NP', 'O')
To date, phenotype- based functional genomics methods have utilized libraries of various genome-regulating biomolecules such as artificial transcription factors, ribozymes, or small interfering RNAs (Lee et al., 2003; Akashi et al., 2005).
('To', 'To', 'TO', 'B-PP', 'O')
('date,', 'date,', 'NN', 'B-NP', 'O')
('phenotype-', 'phenotype-', 'NN', 'I-NP', 'O')
('based', 'base', 'VBN', 'B-VP', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('methods', 'method', 'NNS', 'I-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('utilized', 'utilize', 'VBN', 'I-VP', 'O')
('libraries', 'library', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('genome-regulating', 'genome-regulating', 'JJ', 'I-NP', 'O')
('biomolecules', 'biomolecule', 'NNS', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('artificial', 'artificial', 'JJ', 'B-NP', 'O')
('transcription', 'transcription', 'NN', 'I-NP', 'O')
('factors,', 'factors,', 'NN', 'I-NP', 'O')
('ribozymes,', 'ribozymes,', 'NN', 'I-NP', 'O')
('or', 'or', 'CC', 'O', 'O')
('small', 'small', 'JJ', 'B-NP', 'O')
('interfering', 'interfere', 'VBG', 'I-NP', 'O')
('RNAs', 'RNAs', 'NNP', 'I-NP', 'B-RNA')
('(Lee', '(Lee', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2003;', '2003;', ':', 'O', 'O')
('Akashi', 'Akashi', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2005).', '2005).', 'CD', 'B-NP', 'O')
Escherichia coll RNase P nucleoprotein complex consists of a catalytic RNA subunit (M1 RNA) and a protein subunit (C5 protein).
('Escherichia', 'Escherichia', 'NN', 'B-NP', 'B-protein')
('coll', 'coll', 'NN', 'I-NP', 'I-protein')
('RNase', 'RNase', 'NN', 'I-NP', 'I-protein')
('P', 'P', 'NN', 'I-NP', 'I-protein')
('nucleoprotein', 'nucleoprotein', 'NN', 'I-NP', 'I-protein')
('complex', 'complex', 'NN', 'I-NP', 'I-protein')
('consists', 'consist', 'VBZ', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein')
('RNA', 'RNA', 'NN', 'I-NP', 'I-protein')
('subunit', 'subunit', 'NN', 'I-NP', 'I-protein')
('(M1', '(M1', 'NN', 'I-NP', 'O')
('RNA)', 'RNA)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('protein', 'protein', 'NN', 'I-NP', 'O')
('subunit', 'subunit', 'NN', 'I-NP', 'O')
('(C5', '(C5', 'NN', 'I-NP', 'O')
('protein).', 'protein).', 'NN', 'I-NP', 'O')
It is known that M1 RNA is solely responsible for the catalytic activity of the ribozyme complex (Kole et al., 1981).
('It', 'It', 'PRP', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('known', 'know', 'VBN', 'I-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('M1', 'M1', 'NN', 'B-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('is', 'be', 'VBZ', 'B-VP', 'O')
('solely', 'solely', 'RB', 'B-ADJP', 'O')
('responsible', 'responsible', 'JJ', 'I-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'B-protein')
('complex', 'complex', 'NN', 'I-NP', 'I-protein')
('(Kole', '(Kole', 'NN', 'I-NP', 'O')
('et', 'et', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('1981).', '1981).', 'CD', 'B-NP', 'O')
This catalytic activity of M1 RNA can be used for targeted degradation of RNAs In vivo.
('This', 'This', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'O')
('activity', 'activity', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('M1', 'M1', 'NN', 'B-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('can', 'can', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('targeted', 'target', 'VBN', 'B-NP', 'O')
('degradation', 'degradation', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('RNAs', 'RNA', 'NNS', 'B-NP', 'B-RNA')
('In', 'In', 'IN', 'B-PP', 'O')
('vivo.', 'vivo.', 'NN', 'B-NP', 'O')
It was reported that the expression of hybrid RNA that consists of M1 RNA and a guide sequence which is complementary to the target mRNA efficiently represses target gene expression.
('It', 'It', 'PRP', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hybrid', 'hybrid', 'NN', 'B-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('that', 'that', 'WDT', 'B-NP', 'O')
('consists', 'consist', 'VBZ', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('M1', 'M1', 'NN', 'B-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'B-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('complementary', 'complementary', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('efficiently', 'efficiently', 'RB', 'B-ADVP', 'O')
('represses', 'repress', 'VBZ', 'B-VP', 'O')
('target', 'target', 'NN', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('expression.', 'expression.', 'NN', 'I-NP', 'O')
The hybrid RNA binds the cellular target mRNA via its guide sequence and the catalytic M1 RNA cleaves the target.
('The', 'The', 'DT', 'B-NP', 'O')
('hybrid', 'hybrid', 'NN', 'I-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('binds', 'bind', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cellular', 'cellular', 'JJ', 'I-NP', 'B-RNA')
('target', 'target', 'NN', 'I-NP', 'I-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('via', 'via', 'IN', 'B-PP', 'O')
('its', 'its', 'PRP$', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'B-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'O')
('M1', 'M1', 'NN', 'I-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('cleaves', 'cleave', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('target.', 'target.', 'NN', 'I-NP', 'O')
As a result, target specific gene expression inhibition is accomplished (Raj et al., 2003).
('As', 'As', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('result,', 'result,', 'NN', 'I-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('inhibition', 'inhibition', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('accomplished', 'accomplish', 'VBN', 'I-VP', 'O')
('(Raj', '(Raj', 'NNP', 'B-NP', 'O')
('et', 'et', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2003).', '2003).', 'CD', 'B-NP', 'O')
However, a library-based phenotypic screening based upon the RNase P ribozyme has not yet been reported.
('However,', 'However,', 'WRB', 'B-ADVP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('library-based', 'library-based', 'JJ', 'I-NP', 'O')
('phenotypic', 'phenotypic', 'JJ', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('based', 'base', 'VBN', 'B-VP', 'O')
('upon', 'upon', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'I-protein')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'I-protein')
('has', 'have', 'VBZ', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('yet', 'yet', 'RB', 'I-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('reported.', 'reported.', 'VBN', 'I-VP', 'O')
In this study, an RNase P ribozyme library was constructed which can be utilized as a tool for phenotype­ based functional genomics studies in mammalian cells.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study,', 'study,', 'NN', 'I-NP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('constructed', 'construct', 'VBN', 'I-VP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('utilized', 'utilize', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('tool', 'tool', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('phenotype\xad', 'phenotype\xad', 'NN', 'B-NP', 'O')
('based', 'base', 'VBN', 'B-VP', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('studies', 'study', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('mammalian', 'mammalian', 'JJ', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
The ribozyme library harbors random 18-mers as the guide sequence.
('The', 'The', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'B-DNA')
('library', 'library', 'NN', 'I-NP', 'I-DNA')
('harbors', 'harbor', 'VBZ', 'B-VP', 'O')
('random', 'random', 'JJ', 'B-NP', 'B-protein')
('18-mers', '18-mer', 'NNS', 'I-NP', 'I-protein')
('as', 'as', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'O')
('sequence.', 'sequence.', 'NN', 'I-NP', 'O')
Therefore, when the library is introduced into the cell, the ribozyme RNA expressed from each clone of the library binds a target mRNA complementary to the guide sequence, and successive mRNA cleavage can occur.
('Therefore,', 'Therefore,', 'RB', 'B-ADVP', 'O')
('when', 'when', 'WRB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('introduced', 'introduce', 'VBN', 'I-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cell,', 'cell,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'B-RNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA')
('expressed', 'express', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('clone', 'clone', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('binds', 'bind', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('mRNA', 'mRNA', 'NN', 'I-NP', 'O')
('complementary', 'complementary', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'O')
('sequence,', 'sequence,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('successive', 'successive', 'JJ', 'B-NP', 'O')
('mRNA', 'mRNA', 'NN', 'I-NP', 'O')
('cleavage', 'cleavage', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('occur.', 'occur.', 'VB', 'I-VP', 'O')
After phenotypic screening, the plasmid encoding the ribozymes responsible for the phenotype can be retrieved and sequenced.
('After', 'After', 'IN', 'B-PP', 'O')
('phenotypic', 'phenotypic', 'JJ', 'B-NP', 'O')
('screening,', 'screening,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('plasmid', 'plasmid', 'NN', 'I-NP', 'B-DNA')
('encoding', 'encode', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozymes', 'ribozyme', 'NNS', 'I-NP', 'B-protein')
('responsible', 'responsible', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('phenotype', 'phenotype', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('retrieved', 'retrieve', 'VBN', 'I-VP', 'O')
('and', 'and', 'CC', 'O', 'O')
('sequenced.', 'sequenced.', 'VBN', 'B-VP', 'O')
By analyzing the nucleotide sequence of the guide sequence, the identity of mRNA targeted by the ribozyme can be revealed.
('By', 'By', 'IN', 'B-PP', 'O')
('analyzing', 'analyze', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nucleotide', 'nucleotide', 'NN', 'I-NP', 'B-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'O')
('sequence,', 'sequence,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('identity', 'identity', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('mRNA', 'mRNA', 'NN', 'B-NP', 'B-RNA')
('targeted', 'target', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'B-protein')
('can', 'can', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('revealed.', 'revealed.', 'VBN', 'I-VP', 'O')
The first step to build an RNase P-based ribozyme library was development of a vector system for RNase P ribozyme expression.
('The', 'The', 'DT', 'B-NP', 'O')
('first', 'first', 'JJ', 'I-NP', 'O')
('step', 'step', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('build', 'build', 'VB', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P-based', 'P-based', 'JJ', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('development', 'development', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('RNase', 'RNase', 'NN', 'B-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('expression.', 'expression.', 'NN', 'I-NP', 'O')
To this end, a plasmid named pSUK4 was made which can direct ribozyme synthesis in mammalian cells.
('To', 'To', 'TO', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('end,', 'end,', 'NN', 'I-NP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('plasmid', 'plasmid', 'NN', 'I-NP', 'B-DNA')
('named', 'name', 'VBN', 'B-VP', 'O')
('pSUK4', 'pSUK4', 'NN', 'B-NP', 'B-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('made', 'make', 'VBN', 'I-VP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('direct', 'direct', 'VB', 'I-VP', 'O')
('ribozyme', 'ribozyme', 'NN', 'B-NP', 'B-protein')
('synthesis', 'synthesis', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('mammalian', 'mammalian', 'JJ', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
pSUK4 is derived from the pSUPER plasmid, a vector optimized for short RNA expression in mammalian cells.
('pSUK4', 'pSUK4', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('derived', 'derive', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('pSUPER', 'pSUPER', 'NN', 'I-NP', 'O')
('plasmid,', 'plasmid,', 'NN', 'I-NP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('optimized', 'optimize', 'VBN', 'B-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('short', 'short', 'JJ', 'B-NP', 'O')
('RNA', 'RNA', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('mammalian', 'mammalian', 'JJ', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
Ituses the RNA polymerase Ill-driven H1 promoter for the expression of downstream RNA sequences (Brummelkamp eta/., 2002).
('It', 'It', 'PRP', 'B-NP', 'O')
('uses', 'use', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RNA', 'RNA', 'NN', 'I-NP', 'B-DNA')
('polymerase', 'polymerase', 'NN', 'I-NP', 'I-DNA')
('Ill-driven', 'Ill-driven', 'JJ', 'I-NP', 'I-DNA')
('H1', 'H1', 'NN', 'I-NP', 'I-DNA')
('promoter', 'promoter', 'NN', 'I-NP', 'I-DNA')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('downstream', 'downstream', 'JJ', 'B-NP', 'B-DNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-DNA')
('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA')
('(Brummelkamp', '(Brummelkamp', 'NNP', 'B-NP', 'O')
('eta/.,', 'eta/.,', 'VBD', 'B-VP', 'O')
('2002).', '2002).', 'CD', 'B-NP', 'O')
The selection marker for ampicillin of pSUPER was replaced with kanamycin to facilitate the retrieval of ribozyme-encoding plasmid in the actual phenotypescreening process, especially when reporter plasmid containing the ampicillin resistance marker is co-transfected with the ribozyme vector.
('The', 'The', 'DT', 'B-NP', 'O')
('selection', 'selection', 'NN', 'I-NP', 'O')
('marker', 'marker', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('ampicillin', 'ampicillin', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('pSUPER', 'pSUPER', 'NN', 'B-NP', 'B-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('replaced', 'replace', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('kanamycin', 'kanamycin', 'NN', 'B-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('facilitate', 'facilitate', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('retrieval', 'retrieval', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('ribozyme-encoding', 'ribozyme-encoding', 'JJ', 'B-NP', 'B-DNA')
('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('actual', 'actual', 'JJ', 'I-NP', 'O')
('phenotype', 'phenotype', 'NN', 'I-NP', 'O')
('screening', 'screening', 'NN', 'I-NP', 'O')
('process,', 'process,', 'NN', 'I-NP', 'O')
('especially', 'especially', 'RB', 'B-ADVP', 'O')
('when', 'when', 'WRB', 'B-ADVP', 'O')
('reporter', 'reporter', 'NN', 'B-NP', 'B-DNA')
('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA')
('containing', 'contain', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ampicillin', 'ampicillin', 'NN', 'I-NP', 'O')
('resistance', 'resistance', 'NN', 'I-NP', 'O')
('marker', 'marker', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('co-transfected', 'co-transfecte', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('vector.', 'vector.', 'NN', 'I-NP', 'O')
The cloning strategy of the RNase P ribozyme unit is as follows.
('The', 'The', 'DT', 'B-NP', 'O')
('cloning', 'cloning', 'NN', 'I-NP', 'O')
('strategy', 'strategy', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('unit', 'unit', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('as', 'as', 'RB', 'B-ADJP', 'O')
('follows.', 'follows.', 'JJ', 'I-ADJP', 'O')
First, PCR was performed using an upstream primer including the Bg/ll restriction site and the 5’ end of the M1 RNA sequence and a downstream primer including the 3’ end of the spacer sequence, the 18-mer guide sequence, and the Sal I restriction site.
('First,', 'First,', 'JJ', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('performed', 'perform', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('upstream', 'upstream', 'JJ', 'I-NP', 'B-DNA')
('primer', 'primer', 'NN', 'I-NP', 'I-DNA')
('including', 'include', 'VBG', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Bg/ll', 'Bg/ll', 'NN', 'I-NP', 'B-DNA')
('restriction', 'restriction', 'NN', 'I-NP', 'I-DNA')
('site', 'site', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('5’', '5’', 'NN', 'I-NP', 'O')
('end', 'end', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('M1', 'M1', 'NN', 'I-NP', 'B-DNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('downstream', 'downstream', 'JJ', 'I-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('3’', '3’', 'NN', 'I-NP', 'O')
('end', 'end', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('spacer', 'spacer', 'NN', 'I-NP', 'O')
('sequence,', 'sequence,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('18-mer', '18-mer', 'NN', 'I-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'O')
('sequence,', 'sequence,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Sal', 'Sal', 'JJ', 'I-NP', 'O')
('I', 'I', 'CD', 'I-NP', 'O')
('restriction', 'restriction', 'NN', 'I-NP', 'O')
('site.', 'site.', 'NN', 'I-NP', 'O')
We used M1GS plasmid as a template which containstheMI RNA coding sequence and the spacer sequence (5’- GAAGCTTGACCTGCAGGCATGCAAGCTTGGCGTAATCATGGTCATAGCTGT -3’, Trang ef al., 2003).
('We', 'We', 'PRP', 'B-NP', 'O')
('used', 'use', 'VBD', 'B-VP', 'O')
('M1GS', 'M1GS', 'NN', 'B-NP', 'B-DNA')
('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('template', 'template', 'NN', 'I-NP', 'B-DNA')
('which', 'which', 'WDT', 'B-NP', 'I-DNA')
('containstheMI', 'containstheMI', 'NN', 'B-NP', 'I-DNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-DNA')
('coding', 'coding', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('spacer', 'spacer', 'NN', 'I-NP', 'O')
('sequence', 'sequence', 'NN', 'I-NP', 'O')
('(5’-', '(5’-', 'NN', 'I-NP', 'O')
('GAAGCTTGACCTGCAGGCATGCAAGCTTGGCGTAA', 'GAAGCTTGACCTGCAGGCATGCAAGCTTGGCGTAA', 'NN', 'I-NP', 'O')
('TCATGGTCATAGCTGT', 'TCATGGTCATAGCTGT', 'NN', 'I-NP', 'O')
('-3’,', '-3’,', 'CD', 'I-NP', 'O')
('Trang', 'Trang', 'NNP', 'I-NP', 'O')
('ef', 'ef', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'NN', 'I-NP', 'O')
('2003).', '2003).', 'CD', 'I-NP', 'O')
(See below) Then the synthesized PCR product was cloned into the pSU K4 vector by using the Bgl 11 and the Sal I enzyme.
('(See', '(See', 'NNP', 'B-NP', 'O')
('below)', 'below)', 'IN', 'B-PP', 'O')
('Then', 'Then', 'RB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('synthesized', 'synthesize', 'VBN', 'I-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'B-DNA')
('product', 'product', 'NN', 'I-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('cloned', 'clone', 'VBN', 'I-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('pSU', 'pSU', 'NN', 'I-NP', 'B-DNA')
('K4', 'K4', 'NN', 'I-NP', 'I-DNA')
('vector', 'vector', 'NN', 'I-NP', 'I-DNA')
('by', 'by', 'IN', 'B-PP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Bgl', 'Bgl', 'NN', 'I-NP', 'O')
('11', '11', 'CD', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Sal', 'Sal', 'NNP', 'I-NP', 'O')
('I', 'I', 'PRP', 'B-NP', 'O')
('enzyme.', 'enzyme.', 'VBP', 'B-VP', 'O')
The schematic diagram of the constructed RNase P ribozyme expression vector is shown in Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('schematic', 'schematic', 'JJ', 'I-NP', 'O')
('diagram', 'diagram', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('constructed', 'construct', 'VBN', 'I-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('vector', 'vector', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Fig.', 'Fig.', 'NNP', 'B-NP', 'O')
1.
('1.', '1.', 'LS', 'B-LST', 'O')
To validate efficient suppression of a target gene using our RNase P ribozyme expression system, we designed and tested an EGFP (Enhanced Green Fluorescence Protein)-targeting RNase P ribozyme.
('To', 'To', 'TO', 'B-VP', 'O')
('validate', 'validate', 'VB', 'I-VP', 'O')
('efficient', 'efficient', 'JJ', 'B-NP', 'O')
('suppression', 'suppression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('using', 'use', 'VBG', 'B-VP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('system,', 'system,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('designed', 'design', 'VBD', 'B-VP', 'O')
('and', 'and', 'CC', 'I-VP', 'O')
('tested', 'test', 'VBD', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('EGFP', 'EGFP', 'NN', 'I-NP', 'B-DNA')
('(Enhanced', '(Enhanced', 'NNP', 'I-NP', 'O')
('Green', 'Green', 'NNP', 'I-NP', 'O')
('Fluorescence', 'Fluorescence', 'NNP', 'I-NP', 'O')
('Protein)-targeting', 'Protein)-targeting', 'NNP', 'I-NP', 'O')
('RNase', 'RNase', 'NNP', 'I-NP', 'B-protein')
('P', 'P', 'NNP', 'I-NP', 'O')
('ribozyme.', 'ribozyme.', 'NN', 'I-NP', 'O')
First, we inspected the secondary structure of the EGFP mRNA predicted from the mFOLD program, and chose a region which wasexpected to be the most accessible (Fig 2A).
('First,', 'First,', 'IN', 'B-SBAR', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('inspected', 'inspect', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('secondary', 'secondary', 'JJ', 'I-NP', 'O')
('structure', 'structure', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('EGFP', 'EGFP', 'NN', 'I-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('predicted', 'predict', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('mFOLD', 'mFOLD', 'NN', 'I-NP', 'O')
('program,', 'program,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('chose', 'choose', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('region', 'region', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('expected', 'expect', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('most', 'most', 'RBS', 'I-NP', 'O')
('accessible', 'accessible', 'JJ', 'I-NP', 'O')
('(Fig', '(Fig', 'NNP', 'I-NP', 'O')
('2A).', '2A).', 'NNP', 'I-NP', 'O')
We then designed a downstream primer EGFPDN (5’-CGCGC GGTC GACAAAAATGGTGCTAC CC CGAC C AC ATG AACAGCTATGACCATGATTACGCCAAGCTTGCAT-3’), which contains a guide sequence that can bind the target region of the EGFP mRNA.
('We', 'We', 'PRP', 'B-NP', 'O')
('then', 'then', 'RB', 'B-ADVP', 'O')
('designed', 'design', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('downstream', 'downstream', 'JJ', 'I-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('EGFPDN', 'EGFPDN', 'NN', 'I-NP', 'O')
('(5’-CGCGC', '(5’-CGCGC', 'NN', 'I-NP', 'O')
('GGTC', 'GGTC', 'NN', 'I-NP', 'O')
('GACAAAAATGGTGCTAC', 'GACAAAAATGGTGCTAC', 'NN', 'I-NP', 'O')
('CC', 'CC', 'NN', 'I-NP', 'O')
('CGAC', 'CGAC', 'NN', 'I-NP', 'O')
('C', 'C', 'NN', 'I-NP', 'O')
('AC', 'AC', 'NN', 'I-NP', 'O')
('ATG', 'ATG', 'NN', 'I-NP', 'O')
('AACAGCTATGACCATGATTACGCCAAGCTTGCAT-3’),', 'AACAGCTATGACCATGATTACGCCAAGCTTGCAT-3’),', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('contains', 'contain', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'B-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('that', 'that', 'WDT', 'B-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('bind', 'bind', 'VB', 'I-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'B-DNA')
('region', 'region', 'NN', 'I-NP', 'I-DNA')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('EGFP', 'EGFP', 'NN', 'I-NP', 'O')
('mRNA.', 'mRNA.', 'NN', 'I-NP', 'O')
Next, we performed PCR using the M1UP primer (M1UP, 5’-CGCGCGAGATCTGA AGCTGACCAGACAGTCGC-3’) and the EGFPDN primer, and the PCR product was inserted into pSUK4.
('Next,', 'Next,', 'NN', 'B-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('performed', 'perform', 'VBD', 'B-VP', 'O')
('PCR', 'PCR', 'NN', 'B-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('M1UP', 'M1UP', 'NN', 'I-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('(M1UP,', '(M1UP,', 'NN', 'I-NP', 'O')
('5’-CGCGCGAGATCTGA', '5’-CGCGCGAGATCTGA', 'NN', 'I-NP', 'O')
('AGCTGACCAGACAGTCGC-3’)', 'AGCTGACCAGACAGTCGC-3’)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('EGFPDN', 'EGFPDN', 'NN', 'I-NP', 'B-DNA')
('primer,', 'primer,', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'B-DNA')
('product', 'product', 'NN', 'I-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('inserted', 'insert', 'VBN', 'I-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('pSUK4.', 'pSUK4.', 'NN', 'B-NP', 'O')
The constructed vector, pS/M1-EGFP, was co-transfected with the EGFP expression vector into HEK293 cells.
('The', 'The', 'DT', 'B-NP', 'O')
('constructed', 'construct', 'VBN', 'I-NP', 'O')
('vector,', 'vector,', 'NN', 'I-NP', 'O')
('pS/M1-EGFP,', 'pS/M1-EGFP,', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('co-transfected', 'co-transfecte', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('EGFP', 'EGFP', 'NN', 'I-NP', 'B-DNA')
('expression', 'expression', 'NN', 'I-NP', 'I-DNA')
('vector', 'vector', 'NN', 'I-NP', 'I-DNA')
('into', 'into', 'IN', 'B-PP', 'O')
('HEK293', 'HEK293', 'NN', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
48 hours after transfection, total RNAwas extracted using the Trizol reagent (Invitrogen).
('48', '48', 'CD', 'B-NP', 'O')
('hours', 'hour', 'NNS', 'I-NP', 'O')
('after', 'after', 'IN', 'B-PP', 'O')
('transfection,', 'transfection,', 'NN', 'B-NP', 'O')
('total', 'total', 'JJ', 'I-NP', 'O')
('RNAwas', 'RNAwa', 'NNS', 'I-NP', 'O')
('extracted', 'extract', 'VBN', 'B-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Trizol', 'Trizol', 'NN', 'I-NP', 'O')
('reagent', 'reagent', 'NN', 'I-NP', 'O')
('(Invitrogen).', '(Invitrogen).', 'NNP', 'B-NP', 'O')
The expression of the M1- EGFP RNA molecule was confirmed by RT-PCR (Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('M1-', 'M1-', 'NN', 'I-NP', 'B-protein')
('EGFP', 'EGFP', 'NN', 'I-NP', 'I-protein')
('RNA', 'RNA', 'NN', 'I-NP', 'I-protein')
('molecule', 'molecule', 'NN', 'I-NP', 'I-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('confirmed', 'confirm', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('RT-PCR', 'RT-PCR', 'NN', 'B-NP', 'O')
('(Fig.', '(Fig.', 'NN', 'I-NP', 'O')
2B), and the EGFP mRNA expression level was determined by quantitative real-time PCR analysis.
('2B),', '2B),', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('EGFP', 'EGFP', 'NN', 'I-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('expression', 'expression', 'NN', 'I-NP', 'O')
('level', 'level', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('determined', 'determine', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('quantitative', 'quantitative', 'JJ', 'B-NP', 'O')
('real-time', 'real-time', 'JJ', 'I-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('analysis.', 'analysis.', 'NN', 'I-NP', 'O')
We observed that the expression of EGFP mRNA was reduced to ~50% of the control experiment (Fig.
('We', 'We', 'PRP', 'B-NP', 'O')
('observed', 'observe', 'VBD', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('EGFP', 'EGFP', 'NN', 'B-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('reduced', 'reduce', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('~50%', '~50%', 'NN', 'B-NP', 'B-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('control', 'control', 'NN', 'I-NP', 'O')
('experiment', 'experiment', 'NN', 'I-NP', 'O')
('(Fig.', '(Fig.', 'NNP', 'B-NP', 'O')
2C).
('2C).', '2C).', 'LS', 'B-LST', 'O')
Therefore, the pSUK4-based RNase P ribozyme expression system can repress target gene expression in mammalian cells.
('Therefore,', 'Therefore,', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('pSUK4-based', 'pSUK4-based', 'JJ', 'I-NP', 'B-protein')
('RNase', 'RNase', 'NN', 'I-NP', 'I-protein')
('P', 'P', 'NN', 'I-NP', 'I-protein')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'I-protein')
('expression', 'expression', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('can', 'can', 'MD', 'B-VP', 'O')
('repress', 'repress', 'VB', 'I-VP', 'O')
('target', 'target', 'NN', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('expression', 'expression', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('mammalian', 'mammalian', 'JJ', 'B-NP', 'O')
('cells.', 'cells.', 'NNS', 'I-NP', 'O')
To construct an RNase P ribozyme library with randomized guide sequence, we used a primer set of the upstream primer M1UP and a downstream primer Rd18DN(5-CGCGCGGTCGACAAAAATGGTNNNNNN NNNNN NNNNNNNACAGCTATGACCATGATTACG CAAGCTT GCAT-3’).
('To', 'To', 'TO', 'B-VP', 'O')
('construct', 'construct', 'VB', 'I-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('randomized', 'randomize', 'VBN', 'B-NP', 'O')
('guide', 'guide', 'NN', 'I-NP', 'O')
('sequence,', 'sequence,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('used', 'use', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('set', 'set', 'VBN', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('upstream', 'upstream', 'JJ', 'I-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('M1UP', 'M1UP', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('downstream', 'downstream', 'JJ', 'I-NP', 'O')
('primer', 'primer', 'NN', 'I-NP', 'O')
('Rd18DN', 'Rd18DN', 'NN', 'I-NP', 'O')
('(5-CGCGCGGTCGACAAAAATGGTNNNNNN', '(5-CGCGCGGTCGACAAAAATGGTNNNNNN', 'NN', 'I-NP', 'O')
('NNNNN', 'NNNNN', 'NN', 'I-NP', 'O')
('NNNNNNNACAGCTATGACCATGATTACG', 'NNNNNNNACAGCTATGACCATGATTACG', 'NN', 'I-NP', 'O')
('CAAGCTT', 'CAAGCTT', 'NN', 'I-NP', 'O')
('GCAT-3’).', 'GCAT-3’).', 'NN', 'I-NP', 'O')
The Rd18DN primer has a random 18-mer guide sequence instead of a specific sequence.
('The', 'The', 'DT', 'B-NP', 'O')
('Rd18DN', 'Rd18DN', 'NN', 'I-NP', 'B-DNA')
('primer', 'primer', 'NN', 'I-NP', 'I-DNA')
('has', 'have', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-DNA')
('18-mer', '18-mer', 'NN', 'I-NP', 'I-DNA')
('guide', 'guide', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('instead', 'instead', 'RB', 'B-PP', 'O')
('of', 'of', 'IN', 'I-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('sequence.', 'sequence.', 'NN', 'I-NP', 'O')
After ligation of these PCR products with the pSUK4 vector, the ligation mixture was transformed into E. coli by electroporation.
('After', 'After', 'IN', 'B-PP', 'O')
('ligation', 'ligation', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'B-DNA')
('products', 'product', 'NNS', 'I-NP', 'I-DNA')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('pSUK4', 'pSUK4', 'NN', 'I-NP', 'B-protein')
('vector,', 'vector,', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('ligation', 'ligation', 'NN', 'I-NP', 'O')
('mixture', 'mixture', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('transformed', 'transform', 'VBN', 'I-VP', 'O')
('into', 'into', 'IN', 'B-PP', 'O')
('E.', 'E.', 'FW', 'B-NP', 'O')
('coli', 'coli', 'FW', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('electroporation.', 'electroporation.', 'NN', 'B-NP', 'O')
A total of about 1.4x10' independent colonies was obtained, and plasmid DNA was prepared from the mixture of these colonies.
('A', 'A', 'DT', 'B-NP', 'O')
('total', 'total', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('about', 'about', 'IN', 'B-NP', 'O')
("1.4x10'", "1.4x10'", 'CD', 'I-NP', 'B-cell_line')
('independent', 'independent', 'JJ', 'I-NP', 'I-cell_line')
('colonies', 'colony', 'NNS', 'I-NP', 'I-cell_line')
('was', 'be', 'VBD', 'B-VP', 'O')
('obtained,', 'obtained,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('plasmid', 'plasmid', 'NN', 'I-NP', 'O')
('DNA', 'DNA', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('prepared', 'prepare', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('mixture', 'mixture', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('colonies.', 'colonies.', 'NN', 'I-NP', 'O')
Finally, we checked the random 18-mer sequence from 15 randomly picked colonies and found no bias in the nucleotide composition (Table 1).
('Finally,', 'Finally,', 'NN', 'B-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('checked', 'check', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-DNA')
('18-mer', '18-mer', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('from', 'from', 'IN', 'B-PP', 'O')
('15', '15', 'CD', 'B-NP', 'O')
('randomly', 'randomly', 'RB', 'I-NP', 'O')
('picked', 'picked', 'JJ', 'I-NP', 'O')
('colonies', 'colony', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('found', 'find', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('bias', 'bias', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O')
('composition', 'composition', 'NN', 'I-NP', 'O')
('(Table', '(Table', 'JJ', 'I-NP', 'O')
('1).', '1).', 'CD', 'I-NP', 'O')
In summary, we have developed a novel genomics tool that utilizes the catalytic subunit of RNase P. In this system, the M1 RNA sequence and a random guide sequence are expressed as a single RNA molecule.
('In', 'In', 'IN', 'B-PP', 'O')
('summary,', 'summary,', 'NN', 'B-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('developed', 'develop', 'VBN', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('novel', 'novel', 'JJ', 'I-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('tool', 'tool', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('utilizes', 'utilize', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein')
('subunit', 'subunit', 'NN', 'I-NP', 'I-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('RNase', 'RNase', 'NN', 'B-NP', 'B-protein')
('P.', 'P.', 'NN', 'I-NP', 'O')
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('system,', 'system,', 'NN', 'I-NP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('M1', 'M1', 'NN', 'I-NP', 'B-DNA')
('RNA', 'RNA', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-DNA')
('guide', 'guide', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('are', 'be', 'VBP', 'B-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('single', 'single', 'JJ', 'I-NP', 'O')
('RNA', 'RNA', 'NN', 'I-NP', 'O')
('molecule.', 'molecule.', 'NN', 'I-NP', 'O')
Via the recognition of target mRNA by the random guide sequence followed by mRNA cleavage by the catalytic M1 RNA, gene expression is blocked in a sequence-specific manner.
('Via', 'Via', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('recognition', 'recognition', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('target', 'target', 'NN', 'B-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('random', 'random', 'JJ', 'I-NP', 'B-DNA')
('guide', 'guide', 'NN', 'I-NP', 'I-DNA')
('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA')
('followed', 'follow', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('mRNA', 'mRNA', 'NN', 'B-NP', 'O')
('cleavage', 'cleavage', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-DNA')
('M1', 'M1', 'NN', 'I-NP', 'I-DNA')
('RNA,', 'RNA,', 'NN', 'I-NP', 'I-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('expression', 'expression', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('blocked', 'block', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('sequence-specific', 'sequence-specific', 'JJ', 'I-NP', 'O')
('manner.', 'manner.', 'NN', 'I-NP', 'O')
Using EGFP mRNA as a model target, efficient target gene repression by RNase P ribozyme expression system was confirmed.
('Using', 'Use', 'VBG', 'B-VP', 'O')
('EGFP', 'EGFP', 'NN', 'B-NP', 'B-RNA')
('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA')
('as', 'as', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('target,', 'target,', 'NN', 'I-NP', 'O')
('efficient', 'efficient', 'JJ', 'I-NP', 'O')
('target', 'target', 'NN', 'I-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('repression', 'repression', 'NN', 'I-NP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('RNase', 'RNase', 'NN', 'B-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'I-protein')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'I-protein')
('expression', 'expression', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('confirmed.', 'confirmed.', 'VBN', 'I-VP', 'O')
Finally, we built an RNase P ribozyme library with randomness and complexity suitable for functional genomics studies.
('Finally,', 'Finally,', 'NN', 'B-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('built', 'build', 'VBD', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('RNase', 'RNase', 'NN', 'I-NP', 'B-protein')
('P', 'P', 'NN', 'I-NP', 'O')
('ribozyme', 'ribozyme', 'NN', 'I-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('randomness', 'randomness', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('complexity', 'complexity', 'NN', 'I-NP', 'O')
('suitable', 'suitable', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('studies.', 'studies.', 'NNS', 'I-NP', 'O')
This library system should become a useful addition to the existing libraries for genomeregulation (Lee et al., 2003; Akashi et al., 2005) for phenotype-based functional genomics studies, eventually to uncover novel gene functions.
('This', 'This', 'DT', 'B-NP', 'O')
('library', 'library', 'NN', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('should', 'should', 'MD', 'B-VP', 'O')
('become', 'become', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('useful', 'useful', 'JJ', 'I-NP', 'O')
('addition', 'addition', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('existing', 'exist', 'VBG', 'I-NP', 'O')
('libraries', 'library', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('genome', 'genome', 'NN', 'B-NP', 'O')
('regulation', 'regulation', 'NN', 'I-NP', 'O')
('(Lee', '(Lee', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2003;', '2003;', ':', 'O', 'O')
('Akashi', 'Akashi', 'NNP', 'B-NP', 'O')
('et', 'et', 'FW', 'I-NP', 'O')
('al.,', 'al.,', 'FW', 'I-NP', 'O')
('2005)', '2005)', 'CD', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('phenotype-based', 'phenotype-based', 'JJ', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('genomics', 'genomic', 'NNS', 'I-NP', 'O')
('studies,', 'studies,', 'VBN', 'B-VP', 'O')
('eventually', 'eventually', 'RB', 'B-ADVP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('uncover', 'uncover', 'VB', 'I-VP', 'O')
('novel', 'novel', 'JJ', 'B-NP', 'O')
('gene', 'gene', 'NN', 'I-NP', 'O')
('functions.', 'functions.', 'NN', 'I-NP', 'O')
